What is Elotuzumab?

Category: Prescription Drugs

Most popular types: Empliciti


See also: Elotuzumab-lenalidomide-dexamethasone

Elotuzumab is a monoclonal antibody intended for the treatment of multiple myeloma.


Based on patients currently taking Elotuzumab

Dosage Patients Percentage
300 mg every other week 1


Currently taking Elotuzumab

Duration Patients Percentage
2 - 5 years 1

What people switch to and from

Patients started taking Elotuzumab after stopping:

Treatment Patients Percentage
Bortezomib (Velcade) 1
Last updated:
There are no evaluations for Elotuzumab.